Search for: "ASTRAZENECA LP" Results 81 - 100 of 159
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Feb 2010, 8:00 am by Karen E. Keller
Aquatron Inc. and Aqua Group LLC (patent infringement) 1/7: AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited and AstraZeneca AB v. [read post]
8 Oct 2009, 6:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Seroquel (Quetiapine) – US: CAFC: Sometimes, sins of omission are not inequitable conduct: AstraZeneca Pharmaceuticals LP v. [read post]
25 Aug 2010, 12:37 am by Kelly
Osmotica Pharmaceutical Corp (Patent Docs) Seroquel (Quetiapine) – US: Patent infringement suit filed following Para IV certification: Astrazeneca Pharmaceuticals LP et al. v. [read post]
28 Aug 2009, 8:11 am
Hewlett-Packard Company, AstraZeneca Pharmaceuticals LP, Dow Chemical Company, Advanced Micro Devices, Inc., Dreamworks Animation SKG, et al. [read post]
24 Mar 2012, 1:20 pm by Stewart Walsh
AstraZeneca Pharmaceuticals LP to surprise, and unpleasantly upend the patentee. [read post]
21 Jan 2010, 1:00 am
(Patent Docs) Faslodex (Fulvestrant) - US: Infringement of US Patent following a Paragraph IV certification: AstraZeneca Pharmaceuticals LP et al. v. [read post]
28 Feb 2017, 7:39 am by Dennis Crouch
 The particular claims require “a continuous long term regimen . . . at a dosage up to 1.5 mg/kg/day for not less than 45 days” for treating “an individual with … penile tunical fibrosis …” On anticipation, the court drew a fine-line with its closest case being AstraZeneca LP v. [read post]
10 Nov 2008, 2:07 pm
AstraZeneca Pharmaceuticals LP, the court held that the complexity of having to prove the extent to which there actually was prescribing physician reliance - or none at all - or something in between - required dismissal of a third-party payer suit under Holmes v. [read post]
1 Dec 2010, 12:15 am by Kelly
Navinta LLC (Property, intangible) Pulmicort Respules (Budesonide) – US: Liability for future indirect infringement: AstraZeneca LP v. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Colmetec (Olmesartan medoxomil, hydrochlorothiazide) – France: Cour d’appel de Paris say ‘non’ to olmesartan medoxomil and hydrochlorothiazide combination SPC: Daiichi Sankyo Company v INPI (SPC Blog) Crestor (Rosuvastatin) – US: Generic drug makers, Teva, Apotex and others seek to remove AstraZeneca LP as party in Crestor suit (Patent Docs) Differin (Adapalene) – US: Patent infringement complaint following a Paragraph IV… [read post]
15 Dec 2011, 10:17 am by Bexis
AstraZeneca Pharmaceuticals LP, No. 3:11-cv-04001-JAP-TJB, slip op. [read post]
1 Jun 2011, 11:22 am
Ct. 365, 374 (2008); see also AstraZeneca LP v. [read post]